224 related articles for article (PubMed ID: 26558731)
1. Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.
Nou E; Lu MT; Looby SE; Fitch KV; Kim EA; Lee H; Hoffmann U; Grinspoon SK; Lo J
AIDS; 2016 Feb; 30(4):583-90. PubMed ID: 26558731
[TBL] [Abstract][Full Text] [Related]
2. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK
Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461
[TBL] [Abstract][Full Text] [Related]
3. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.
Hileman CO; Turner R; Funderburg NT; Semba RD; McComsey GA
AIDS; 2016 Jan; 30(1):65-73. PubMed ID: 26731754
[TBL] [Abstract][Full Text] [Related]
4. Novel mediators of statin effects on plaque in HIV: a proteomics approach.
deFilippi C; Lo J; Christenson R; Grundberg I; Stone L; Zanni MV; Lee H; Grinspoon SK
AIDS; 2018 Apr; 32(7):867-876. PubMed ID: 29369166
[TBL] [Abstract][Full Text] [Related]
5. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
[TBL] [Abstract][Full Text] [Related]
6. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
Karpouzas GA; Ormseth SR; Ronda N; Hernandez E; Budoff MJ
J Autoimmun; 2022 May; 129():102815. PubMed ID: 35366608
[TBL] [Abstract][Full Text] [Related]
8. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
Lu MT; Ribaudo H; Foldyna B; Zanni MV; Mayrhofer T; Karady J; Taron J; Fitch KV; McCallum S; Burdo TH; Paradis K; Hedgire SS; Meyersohn NM; DeFilippi C; Malvestutto CD; Sturniolo A; Diggs M; Siminski S; Bloomfield GS; Alston-Smith B; Desvigne-Nickens P; Overton ET; Currier JS; Aberg JA; Fichtenbaum CJ; Hoffmann U; Douglas PS; Grinspoon SK;
JAMA Cardiol; 2024 Apr; 9(4):323-334. PubMed ID: 38381407
[TBL] [Abstract][Full Text] [Related]
9. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
[TBL] [Abstract][Full Text] [Related]
10. Individual coronary plaque changes on serial CT angiography: Within-patient heterogeneity, natural history, and statin effects in HIV.
Foldyna B; Lo J; Mayrhofer T; Grinspoon SK; Hoffmann U; Lu MT
J Cardiovasc Comput Tomogr; 2020; 14(2):144-148. PubMed ID: 31451438
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
12. Human pericoronary adipose tissue as storage and possible supply site for oxidized low-density lipoprotein and high-density lipoprotein in coronary artery.
Uchida Y; Uchida Y; Shimoyama E; Hiruta N; Kishimoto T; Watanabe S
J Cardiol; 2017 Jan; 69(1):236-244. PubMed ID: 27209423
[TBL] [Abstract][Full Text] [Related]
13. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.
Hoffmann U; Lu MT; Foldyna B; Zanni MV; Karady J; Taron J; Zhai BK; Burdo T; Fitch KV; Kileel EM; Williams K; Fichtenbaum CJ; Overton ET; Malvestutto C; Aberg J; Currier J; Sponseller CA; Melbourne K; Floris-Moore M; Van Dam C; Keefer MC; Koletar SL; Douglas PS; Ribaudo H; Mayrhofer T; Grinspoon SK;
JAMA Netw Open; 2021 Jun; 4(6):e2114923. PubMed ID: 34185068
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
16. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).
Nixon DE; Bosch RJ; Chan ES; Funderburg NT; Hodder S; Lake JE; Lederman MM; Klingman KL; Aberg JA;
J Clin Lipidol; 2017; 11(1):61-69. PubMed ID: 28391912
[TBL] [Abstract][Full Text] [Related]
18. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
Azar RR; Badaoui G; Sarkis A; Azar M; Aydanian H; Harb S; Achkouty G; Kassab R
Am J Cardiol; 2010 Jul; 106(2):193-7. PubMed ID: 20599002
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty.
Kougialis S; Skopelitis E; Gialernios T; Nikolaou S; Kroustalis A; Katsadorou E; Gialernios K; Zervou A; Gika E; Polydorou A; Polydorou V; Drakoulis C; Iliopoulos N; Dermitzakis I; Mpilinis H; Polydorou A
Int Angiol; 2010 Aug; 29(4):338-47. PubMed ID: 20671652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
